This mechanism is also involved in conventional white adipose tissue browning induced by β3AR-activation, and may thus deliver therapeutic targets for the prevention or treatment of obesity-associated metabolic disorders. Here, ADRB3 is linked to obesity due to melanocortin 4 receptor deficiency.